{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:17:37Z","timestamp":1785849457258,"version":"3.56.0"},"reference-count":85,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"vor","delay-in-days":198,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Dermatology Research and Practice"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>Neutrophilic dermatoses, including pyoderma gangrenosum (PG) and Sweet syndrome (SS), are inflammatory disorders characterized by neutrophilic infiltration without infection. Conventional therapies are often inadequate. We aim to evaluate the efficacy and safety of JAK inhibitors (JAK\u2010I) in the treatment of PG and SS. The study was registered (PROSPERO\u2010CRD420251113331), and a relevant search was conducted on PubMed\/MEDLINE, Scopus, Web of Science, and Embase until July 27, 2025. Included studies were English language reports describing PG or SS treated with any JAK\u2010I or cases of JAK\u2010I\u2013associated SS. Reviews, animal studies, and reports with insufficient clinical data were excluded. Four reviewers independently screened records. Data extraction included demographics, comorbidities, treatment regimens, outcomes, and adverse events. Risk of bias was assessed using the National Heart, Lung, and Blood Institute and Murad et al. tools through discussion\u2010based consensus. Due to heterogeneous outcome definitions and small sample sizes, only descriptive synthesis was performed. Fifty\u2010four reports, including 70 patients (59 PG, 5 SS) treated with JAK\u2010I and 6 JAK\u2010I\u2013associated SS, were included. Across 43 PG studies, five JAK\u2010Is\u2014tofacitinib, upadacitinib, baricitinib, abrocitinib, and ruxolitinib\u2014produced 33 complete and 26 partial responses. Twenty\u2010six patients (44.1%) received monotherapy. Most patients (51\/59; 86.4%) had at least one comorbidity. Adverse events occurred in 6 (10.1%), including anemia, hypertension, renal dysfunction, fatigue, and acneiform eruption. Among 11 SS reports, all 5 treated patients achieved complete resolution with baricitinib, ruxolitinib, or filgotinib. Six additional cases described ruxolitinib\u2010associated SS, generally improving with corticosteroids or drug withdrawal. Most studies were rated good quality. Evidence is limited to small cases with heterogeneous outcome definitions, variable dosing, and inconsistent follow\u2010up. JAK\u2010Is are associated with clinical improvement in PG and selected SS cases and may serve as useful adjunct therapies, though caution is needed in patients with hematologic malignancies. Larger controlled studies are needed.<\/jats:p>","DOI":"10.1155\/drp\/7086209","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T09:36:47Z","timestamp":1784367407000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["JAK Inhibitors for Treatment of Pyoderma Gangrenosum and Sweet Syndrome: A Systematic Review of Published Case Reports"],"prefix":"10.1155","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4736-6803","authenticated-orcid":false,"given":"Seyed Mohammad","family":"Vahabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2683-3750","authenticated-orcid":false,"given":"Sama","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8220-4952","authenticated-orcid":false,"given":"Yalda","family":"Farahmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4069-7289","authenticated-orcid":false,"given":"Elnaz","family":"Pourgholi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4768-0598","authenticated-orcid":false,"given":"Nika","family":"Kianfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0104-5350","authenticated-orcid":false,"given":"Huria","family":"Memari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2265-9995","authenticated-orcid":false,"given":"Farzad","family":"Esmaeili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5855-6843","authenticated-orcid":false,"given":"Saeed","family":"Bahramian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3026-2485","authenticated-orcid":false,"given":"Ifa","family":"Etesami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8586-2432","authenticated-orcid":false,"given":"Mahshid Sadat","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,18]]},"reference":[{"key":"e_1_2_11_1_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13671-022-00355-8"},{"key":"e_1_2_11_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2012.04375.x"},{"key":"e_1_2_11_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0213-x"},{"key":"e_1_2_11_4_2","doi-asserted-by":"publisher","DOI":"10.1159\/000530519"},{"key":"e_1_2_11_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106210"},{"key":"e_1_2_11_6_2","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201900447","article-title":"Ligand-Induced IFNGR1 Down-Regulation Calibrates Myeloid Cell IFN\u03b3 Responsiveness","volume":"2","author":"Crisler W. J.","year":"2019","journal-title":"Life Science Alliance"},{"key":"e_1_2_11_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2023.03.001"},{"key":"e_1_2_11_8_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2025.05.1377","article-title":"Use of the Oral JAK Inhibitor Tofacitinib in the Treatment of Morphea: A Retrospective Study","author":"Ansari M. S.","year":"2025","journal-title":"Journal of the American Academy of Dermatology"},{"key":"e_1_2_11_9_2","article-title":"Eosinophilic Fasciitis and Morphea Share Gene Signatures of Inflammatory Cell Death, Self-DNA Recognition, and Enhanced JAK\/Signal Transducer and Activator of Transcription Signaling","author":"Crisler W. J.","year":"2025","journal-title":"Journal of Investigative Dermatology"},{"key":"e_1_2_11_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.72301"},{"key":"e_1_2_11_11_2","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page M. J.","year":"2021","journal-title":"BMJ"},{"key":"e_1_2_11_12_2","article-title":"Methodological Quality and Synthesis of Case Series and Case Reports","author":"Murad M. H.","year":"2018","journal-title":"BMJ Evidence-Based Medicine"},{"key":"e_1_2_11_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izab176"},{"key":"e_1_2_11_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izz015"},{"key":"e_1_2_11_15_2","doi-asserted-by":"publisher","DOI":"10.1177\/2050313x241235444"},{"key":"e_1_2_11_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/jvc2.534"},{"key":"e_1_2_11_17_2","doi-asserted-by":"publisher","DOI":"10.3389\/jcia.2025.14079"},{"key":"e_1_2_11_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-023-06506-x"},{"key":"e_1_2_11_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-024-05560-1"},{"key":"e_1_2_11_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185x.14810"},{"key":"e_1_2_11_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14778"},{"key":"e_1_2_11_22_2","first-page":"733","article-title":"Tofacitinib, a Useful Option for the Treatment of Pyoderma Gangrenosum in an Ulcerative Colitis Patient","volume":"113","author":"Olavarr\u00eda P. S.","year":"2021","journal-title":"Revista Espa\u00f1ola de Enfermedades Digestivas"},{"key":"e_1_2_11_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14683"},{"key":"e_1_2_11_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2020.07.035"},{"key":"e_1_2_11_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.10.047"},{"key":"e_1_2_11_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.16676"},{"key":"e_1_2_11_27_2","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.idoj_231_24"},{"key":"e_1_2_11_28_2","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.ijd_1109_23"},{"key":"e_1_2_11_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izab005"},{"key":"e_1_2_11_30_2","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v103.9646"},{"key":"e_1_2_11_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/jvc2.62"},{"key":"e_1_2_11_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.17200"},{"key":"e_1_2_11_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/olq.0000000000001984"},{"key":"e_1_2_11_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-024-02958-6"},{"key":"e_1_2_11_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185x.15275"},{"key":"e_1_2_11_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2021.100099"},{"key":"e_1_2_11_37_2","doi-asserted-by":"publisher","DOI":"10.2147\/ccid.s446369"},{"key":"e_1_2_11_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2025.02.022"},{"key":"e_1_2_11_39_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v31.i20.104038"},{"key":"e_1_2_11_40_2","doi-asserted-by":"publisher","DOI":"10.25251\/jfe9bk61"},{"key":"e_1_2_11_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2023.05.045"},{"key":"e_1_2_11_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.07.058"},{"key":"e_1_2_11_43_2","doi-asserted-by":"crossref","DOI":"10.1111\/ddg.14716","volume-title":"Response of Rheumatoid Arthritis\u2010Associated Pyoderma Gangrenous to the JAK1 Inhibitor Upadacitinib","author":"Kooybaran N. R.","year":"2022"},{"key":"e_1_2_11_44_2","doi-asserted-by":"publisher","DOI":"10.14309\/crj.0000000000001531"},{"key":"e_1_2_11_45_2","doi-asserted-by":"publisher","DOI":"10.14740\/jocmr5005"},{"key":"e_1_2_11_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2023.05.016"},{"key":"e_1_2_11_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.16791"},{"key":"e_1_2_11_48_2","doi-asserted-by":"publisher","DOI":"10.14309\/crj.0000000000001442"},{"key":"e_1_2_11_49_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2024.11.021"},{"key":"e_1_2_11_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2024.03.016"},{"key":"e_1_2_11_51_2","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljaf085.433"},{"key":"e_1_2_11_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajmo.2025.100112"},{"key":"e_1_2_11_53_2","doi-asserted-by":"publisher","DOI":"10.14309\/01.ajg.0001044808.71041.dd"},{"key":"e_1_2_11_54_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16468"},{"key":"e_1_2_11_55_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.jfas.2013.07.003"},{"key":"e_1_2_11_56_2","first-page":"8","article-title":"Sweet syndrome Successfully Treated With Ruxolitinib in JAK-2 Positive Myeloproliferative Disorder","volume":"2","author":"Melboucy-Belkhir S.","year":"2017","journal-title":"Int Arch Intern Med"},{"key":"e_1_2_11_57_2","article-title":"Successful Use of Filgotinib in the Treatment of Refractory Rheumatoid Arthritis-Associated Sweet syndrome","volume":"2766","author":"Colina M.","year":"2025","journal-title":"Journal ISSN"},{"key":"e_1_2_11_58_2","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14712"},{"key":"e_1_2_11_59_2","doi-asserted-by":"publisher","DOI":"10.1093\/ced\/llad245"},{"key":"e_1_2_11_60_2","article-title":"Refractory Sweet Syndrome Successfully Treated With Ruxolitinib","author":"Korbl J.","year":"2022","journal-title":"Australasian Journal of Dermatology"},{"key":"e_1_2_11_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.07.3586"},{"key":"e_1_2_11_62_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13717"},{"key":"e_1_2_11_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2020.07.037"},{"key":"e_1_2_11_64_2","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-228076"},{"key":"e_1_2_11_65_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.8491-16"},{"key":"e_1_2_11_66_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13334"},{"key":"e_1_2_11_67_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13670"},{"key":"e_1_2_11_68_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01468-7"},{"key":"e_1_2_11_69_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164080"},{"key":"e_1_2_11_70_2","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-2-34"},{"key":"e_1_2_11_71_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.70101"},{"key":"e_1_2_11_72_2","doi-asserted-by":"publisher","DOI":"10.1155\/drp\/9127126"},{"key":"e_1_2_11_73_2","article-title":"Janus Kinase Inhibitors for the Treatment of Prurigo Nodularis: A Systematic Review of 211 Patients","author":"Vahabi S. M.","year":"2026","journal-title":"Journal of Dermatology"},{"key":"e_1_2_11_74_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202250075"},{"key":"e_1_2_11_75_2","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14461"},{"key":"e_1_2_11_76_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16050861"},{"key":"e_1_2_11_77_2","doi-asserted-by":"publisher","DOI":"10.1155\/jskc\/3103865"},{"key":"e_1_2_11_78_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224049"},{"key":"e_1_2_11_79_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2023.4090"},{"key":"e_1_2_11_80_2","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.70122"},{"key":"e_1_2_11_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdin.2024.09.012"},{"key":"e_1_2_11_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2018.09.003"},{"key":"e_1_2_11_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2022.08.005"},{"key":"e_1_2_11_84_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-025-04146-z"},{"key":"e_1_2_11_85_2","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.70733"}],"container-title":["Dermatology Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/drp\/7086209","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1155\/drp\/7086209","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/drp\/7086209","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T09:36:50Z","timestamp":1784367410000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/drp\/7086209"}},"subtitle":[],"editor":[{"given":"Anjali","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1155\/drp\/7086209"],"URL":"https:\/\/doi.org\/10.1155\/drp\/7086209","archive":["Portico"],"relation":{},"ISSN":["1687-6105","1687-6113"],"issn-type":[{"value":"1687-6105","type":"print"},{"value":"1687-6113","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-10-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"7086209"}}